Patents by Inventor Guillaume Michel Jacques Garivet

Guillaume Michel Jacques Garivet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240116916
    Abstract: The present invention relates to a method for preparing 2-[2-(2-chlorothiazol-5-yl)-2- hydroxy-ethyl]sulfanyl-6-hydroxy-3-methyl-5-phenyl-pyrimidin-4-one or a tautomer thereof or enantiomerically enriched forms thereof, to 2-[2-(2-chlorothiazol-5-yl)-2-hydroxy-ethyl]sulfanyl-6-hydroxy-3-methyl-5-phenyl-pyrimidin-4-one or a tautomer thereof or enantiomerically enriched forms thereof, and to the use thereof as intermediate in the preparation of 2,3-dihydrothiazolo[3,2-a]pyrimidinium compounds, specifically of 3-(2-chlorothiazol-5-yl)-8-methyl-7-oxo-6-phenyl-2,3-dihydrothiazolo [3,2-a]pyrimidin-4-ium-5-olate and enantiomerically enriched forms thereof.
    Type: Application
    Filed: January 21, 2022
    Publication date: April 11, 2024
    Inventors: Martin John McLaughlin, Christopher Koradin, Rahul Kaduskar, Harish Shinde, Roland Gotez, Guillaume Michel Jacques Garivet
  • Publication number: 20240101547
    Abstract: The present invention relates to a method for preparing 2-[2-(2-chlorothiazol-5-yl)-2-oxo-ethyl]sulfanyl-6-hydroxy-3-methyl-5-phenyl-pyrimidin-4-one or a tautomer thereof, to 2-[2-(2-chlorothiazol-5-yl)-2-oxo-ethyl]sulfanyl-6-hydroxy-3-methyl-5-phenyl-pyrimidin-4-one or a tautomer thereof and to its use as intermediate in the preparation of 2,3-dihydrotheiazolo [3,2-a]pyrimidinium compounds, and specifically of 3-(2-chlorothiazol-5-yl)-8-methyl-7-oxo-6-phenyl-2,3-dihydrothiazolo [3,2-a]pyrimidin-4-ium-5-olate and enantiomerically enriched forms thereof.
    Type: Application
    Filed: January 21, 2022
    Publication date: March 28, 2024
    Inventors: Christopher Koradin, Martin John McLaughlin, Roland Goetz, Rahul Kaduskar, Harish Shinde, Guillaume Michel Jacques Garivet
  • Publication number: 20230183171
    Abstract: The present invention relates to a process for the preparation of substituted 4-(N?-hydroxy-carbamimidoyl)benzoic acids, which can be obtained by nitrilase catalyzed hydration of substituted terephthalonitriles of formula (II) in an aqueous medium to afford (ammonium) 4-cyanobenzoic acids (IIa). The hydration is followed by treatment of the aqueous reaction medium with hydroxylamine or a salt thereof to afford amidoximes (I).
    Type: Application
    Filed: May 20, 2021
    Publication date: June 15, 2023
    Inventors: Florian Vogt, Kailaskumar Borate, Bernd Wolf, Joachim Gebhardt, Guillaume Michel Jacques Garivet, Harish Shinde, Roland Goetz